Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
https://doi.org/10.14412/1996-7012-2012-752
Abstract
Ankylosing spondylitis (AS) is one of the major inflammatory diseases that affect the vertebral column and joints. The first-line drugs for the treatment of this disease are now nonsteroidal anti-inflammatory drugs (NSAIDs) that not only reduce painful sensations and rigidity, but also retard the radiological progression of AS. Celecoxib is one of the effective and safe NDAIDs that are promising for the treatment of AS.
References
1.
Review
For citations:
Korsakova YL. Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2012;6(3):74-77. (In Russ.) https://doi.org/10.14412/1996-7012-2012-752
Views:
1141
Email this article 